Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Prescient Medicine, Erasmus MC Partner to Study Opioid Addiction Risk Test

Prescient Medicine, Erasmus MC Partner to Study Opioid Addiction Risk Test

Dec 12, 2019
|
staff reporter

NEW YORK — Prescient Medicine said this week that it has partnered with Dutch medical research institute Erasmus MC to evaluate its opioid addiction risk technology in a clinical study in the Netherlands.

Prescient offers a tes, called LifeKit Predict that is designed to determine an individual's risk of opioid addiction by analyzing 16 genes in the brain's reward pathway. The assay uses multiplexed PCR and nucleic acid hybridization to analyze DNA extracted from buccal swabs.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Director of Both, For Now

Kelvin Droegemeier, the director of the White House Office of Science and Technology Policy, is the new acting director of the US National Science Foundation.

Behind on Testing

An opinion piece at the Guardian discusses the state of SARS-CoV-2 testing in the UK.

From CRISPR Lab to COVID-19 Lab

Wired reports the University of California, Berkeley's Innovative Genomics Institute has transformed itself into a diagnostic lab to run SARS-CoV-2 tests.

Nature Papers Present New CRISPR Screening Approach, Discuss CRISPR in Crop Breeding, More

In Nature this week: direct-capture Perturb-seq approach for combinatorial single-cell CRISPR screens, potential uses of genome-editing in breeding crops, and more.

May
06
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

What's Popular?

In PCR

  1. FDA Releases New EUA Guidance for MDx Labs Offering SARS-CoV-2 Testing

  2. Despite Potential, Experts Debate Whether Decentralized MDx for Coronavirus Can Flatten Curve

  3. Color Gears Up to Enter COVID-19 Testing Space

  4. Qiagen Receives FDA Emergency Use Authorization for SARS-CoV-2 Respiratory Panel

  5. Nuclein Exits Stealth Mode With Disposable Handheld qPCR System, COVID-19 Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.